Zacks Investment Research
07 Aug 2026, 00:31 UTC · 6w ago
Verdict
Headline takes no side. We score SKIN −0.30 across four claims — moderately bearish.
−0.30moderately bearish
More negative than 70% of ticker scores this week
What the story claims
4 claims · scored −1 bearish … +1 bullish
SkinHealth Systems Inc. (SKIN) reported a year-over-year revenue decline of 7.8% to $72.1 million for the quarter ended June 2026.
So whatA contraction in top-line growth generally indicates weakening demand or pricing power, which is fundamentally negative for valuation.
More negative than 87% of claims this week
SkinHealth Systems Inc. reported an EPS of -$0.02, a decline from the $0.03 EPS reported in the prior year's quarter.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 1 mover · tap to explore
More negative than 79% of claims this week
SkinHealth Systems Inc. delivered an EPS surprise of 50% against the Zacks Consensus Estimate of -$0.04.
More positive than 50% of claims this week
SkinHealth Systems Inc. revenue of $72.1 million was a -1.96% surprise relative to the Zacks Consensus Estimate of $73.54 million.
More negative than 66% of claims this week
Which stocks this story touches
More negative than 70% of ticker scores this week
The company reported a year-over-year revenue decline of 7.8% and a revenue miss relative to consensus estimates.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
−11.9%
Price agrees with the score
$0.6767 vs $0.7678 close before publication (Aug 6) · not market-adjusted
SKIN chart →
